The Mass General Brigham Heart Failure & Shock Course
- Continuing Education
Explore the latest advances in heart failure and cardiogenic shock management through a comprehensive, multidisciplinary symposium featuring expert-led sessions on diagnosis, treatment strategies, mechanical circulatory support, and complex case discussions. Gain practical, evidence-based insights into emerging heart failure therapies, specialized cardiomyopathies, genetic testing, and the management of unique patient populations across the spectrum of cardiovascular care.
- Live Online or In Person
This course is taught in person and online in real time.
Additionally, all sessions will be recorded and made available to participants for online viewing for 60 days after the end of the course.
Fairmont Copley Hotel | 138 St James Ave, Boston, MA 02116
$499
This is the standard price, for a full list of profession pricing see below.
View All
Continuing Education
Earn up to:
20.75 AMA PRA Category 1 Credit(s) ™
View All
Three Days
Please view the Schedule for a full description of the program.
On This Page
Overview
This Comprehensive Mass General Brigham Heart Failure & Shock symposium will provide practical insights for all clinicians who manage patients with heart failure (HF) and cardiogenic shock. This offering is a two-part course, of which participants can choose to partake in one or both parts. The first day of this three-day course will be an in-depth review of cardiogenic shock while the next two days focus on the latest HF innovations with an emphasis on the multidisciplinary approach to treating HF patients.
For the Shock course, expert speakers will address state-of-the-art issues including: up-to-date knowledge of cardiogenic shock pathophysiology, shock phenotypes, and trajectories; best practices in shock diagnosis and management; the roles of temporary mechanical circulatory support, and challenging case discussions.
For the HF course, leaders in the field will discuss: general HF management across the spectrum of EF, pathology of the failing heart, the fifth pillar - when medications are not enough, HFpEF GDMT in 2027, special cardiomyopathies, and genetic testing (valvular, hypertrophic, inflammatory, amyloid, and cancer-induced). There will be sessions on navigating special issues in the context of HF, such as pregnancy, obesity, and palliative care referral.
The symposium will illustrate the Mass General Brigham Heart Failure Section's comprehensive approach to the management of heart failure and cardiogenic shock for all cardiovascular clinicians.
Learning Objectives
- Critically evaluate current knowledge gaps in cardiogenic shock and assess the design, objectives, and potential clinical implications of emerging and upcoming clinical trials.
- Summarize the mechanisms and indications of vasoactive drugs used in cardiogenic shock.
- Describe the indications and managements of temporary mechanical circulatory support, including VA-ECMO, and transitioning to durable LVAD or transplant.
- Explain the role of palliative care in the comprehensive management of patients with shock, including symptom management, goals-of-care discussions, and alignment of treatment with patient-centered outcomes.
- Explain the pathophysiology of HF and describe the diagnostic evaluation of a patient presenting with HF.
- Describe current evidence-based medical and device therapeutics for HFrEF and HFpEF.
- Describe the diagnostic and therapeutic approaches for special cardiomyopathies (valvular, amyloid, hypertrophic, and cancer-related).
- Describe the clinical indications for cardiopulmonary exercise stress testing and interpret key findings to guide diagnosis, prognosis, and management decisions.
- Summarize the management of arrhythmias, right heart failure, and obesity.
- Summarize the role of artificial intelligence in HF management.
Developed and Offered By:
Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Massachusetts General Hospital.
Who Should Participate
Nurses, Physician Assistants, Specialty Physicians, Pharmacists, Nurse Practitioners, and Primary Care Physicians
Schedule
All agenda sessions are in Eastern Time.
Thursday, January 21, 2027
Introduction and Welcome
8:10-8:15 am
Keynote: Cardiogenic Shock in 2027: Beyond Rescue Toward Precision, Recovery, and Systems of Care
8:15-8:30 am
Q&A
8:30-8:35 am
Talk 1: Hemodynamics Matter: From Bedside to Advanced Profiling
8:35-8:45 am
Talk 2: Inotropes and Vasopressors: Friends or foes?
8:45-8:55 am
Talk 3: Hemodynamic Dissonance: Beyond Flow
8:55-9:05 am
Q&A
9:05-9:20 am
Case (#1): Recognizing Shock Phenotype and Choosing Initial Stabilization
9:20-10:05 am
Break/ Exhibit Hall
10:05-10:20 am
Talk 4: tMCS gallery: Mechanisms, Strengths and Limitations
10:20-10:30 am
Talk 5: tMCS: Troubleshooting Alarms, Position and Unloading Failure
10:30-10:40 am
Talk 6: tMCS as Physiological Support: Unloading, Recovery, and Bridge Strategy
10:40-10:50 am
Q & A
10:50-11:05 am
Break
11:05-11:15 am
Case #2: Choosing, Escalating, and Weaning Temporary Mechanical Support
11:15 am-12:00 pm
Lunch Break
12:00-2:00 pm
Debate
2:00-2:20 pm
In HF-Cardiogenic Shock, Early Transfer to an Advanced Shock Center Should Precede Prolonged Local Escalation
2:00-2:20 pm
Q&A
2:20-2:25 pm
Talk 7: VA-ECMO in Cardiogenic Shock — Indications, Hazards, and Optimal Use
2:25-2:35 pm
Talk 8: ECMO configurations: the Right Circuit for the Right Problem
2:35-2:45 pm
Talk 9: Regional Systems of Care for ECMO and Mobile ECMO: Building a functional Network
2:45-2:55 pm
Q&A
2:55-3:05 pm
Break
3:05-3:15 pm
Case #3: ECMO Strategy, Transfer Decisions, and Failure to Recover
3:15-3:45 pm
Break
3:45-4:00 pm
Talk 10: “Exit Strategies" from Shock and tMCS: Considerations for Heart Replacement Therapies
4:00-4:10 pm
Talk 11: Shared Decision Making Under Crisis in Futility
4:10-4:20 pm
Talk 12: Palliative care: Concurrent Support, Communication, and End-of-Life Planning
4:20-4:30 pm
Q & A
4:30-4:45 pm
Take Home
4:45-4:55 pm
Friday, January 22, 2027
Welcome back
8:00-8:05 am
Heart Failure in 2027
8:05-8:20 am
Beyond the Left: Why the Right Side is the Real Maverick in Heart Failure
8:20-8:35 am
Seeing the Unseen: Diagnostic Imaging in Heart Failure
8:35-8:50 am
Primary prevention of SCD in nonischemic Cardiomyopathy: Have the Goal Posts Moved?
8:50-9:05 am
Case 1
9:05-9:20 am
Panel Q &A
9:20-9:35 am
Break
9:35-9:50 am
Device based Disease Management: Rise of the implantable Sensor
9:50-10:05 am
Acute heart failure with worsening renal function: novel pharmacologic and device strategies for decongestion
10:05-10:20 am
Iron as a Disease Modifier
10:20-10:35 am
Sex, Drugs, and Rock ‘n Roll: A Discussion of Alcohol, THC, and Sexual Dysfunction
10:35-10:50 am
Case 2
10:50-11:05 am
Panel Q & A
11:05-11:20 am
The Broken Pump: Architecture of the Failing Heart
11:20-11:50 am
Panel Q&A
11:50 am-12:00 pm
Lunch Break
12:00-1:00 pm
The 4 Pillar Playbook: Decoding the “Who, When, and Wow” for HFrEF
1:00-1:15 pm
Back to the Future: Cardiac Glycosides Revisited
1:15-1:25 pm
Evolution of Pacing Strategies in HFrEF
1:25-1:40 pm
Outsmarting the Heart: Autonomic Modulation
1:40-1:50 pm
Beyond Pacing: Powering up the Failing Heart with CCM
1:50-2:00 pm
Clinical Pearls in HF Management
2:00-2:30 pm
Panel Q & A
2:30-2:45 pm
Break
2:45-3:00 pm
Evolution of GDMT for HFpEF
3:00-3:15 pm
Obesity in HFpEF
3:15-3:30 pm
RV Pulmonary Vascular Dysfunction in HFpEF: Sotatercept, Levosimendan or Denervation to the Rescue?
3:30-3:45 pm
Case 3
3:45-4:00 pm
Panel Q & A
4:00-4:20 pm
Wrap Up
4:20-4:30 pm
Saturday, January 23, 2027
Welcome
8:00-8:05 am
Genetic testing for Cardiomyopathy
8:05-8:15 am
Hypertrophic Cardiomyopathy: Myosin Inhibitors and beyond
8:15-8:30 am
Hypertrophic Cardiomyopathy: Navigating the Path from HCM to HF
8:30-8:45 am
Unique Hearts, Unique Needs: Adult Congenital Heart Failure is not “regular” Heart Failure
8:45-9:05 am
Panel Q&A
9:05-9:15 am
Inflammatory Cardiomyopathies
9:15-9:35 am
Mastering the Misfold of TTR Cardiac Amyloid from Diagnosis to Disease Modification
9:35-9:50 am
The Toxicity of Light: Understanding AL Cardiac Amyloid
9:50-10:05 am
The Heart Cancer Collision: Saving Lives without Breaking Hearts - Cancer Induced Cardiomopathy
10:05-10:20 am
Panel Q & A
10:20-10:35 am
Break
10:35-10:50 am
Fixing the Flow: Revascularization in HF
10:50-11:05 am
Surgical vs Interventional Approach to MR
11:05-11:30 am
Structural Solutions for Functional Problems: The TEER and TTVR Evolution for TR
11:30-11:50 am
Case 1
11:50 am-12:05 pm
Panel Q&A
12:05-12:15 pm
Lunch Break
12:15-1:15 pm
Stop Waiting, Start Advancing: The Art of the Timely Referral for Advanced Therapies
1:15-1:30 pm
Palliative care: Tender Care for Tough Hearts
1:30-1:45 pm
Knowledgeable Together: The Secret to Better HF Outcomes
1:45-2:00 pm
Shared Care Cases and Roundtable
2:00-2:45 pm
Panel Q & A
2:45-3:00 pm
Break
3:00-3:15 pm
CPET Challenge
3:15-3:45 pm
When Two Hearts Beat as One (Unsafely): Navigating Pregnancy with Heart Failure
3:45-4:00 pm
Taming the Two-Headed Monster: Mastering AF and HF together
4:00-4:15 pm
Heart Failure AI: Predicting Tomorrow’s Failure Today
4:15-4:30 pm
Panel Q & A
4:30-4:45 pm
Closing Remarks
4:45-4:50 pm
Faculty
Harvard Medical School Continuing Education offers faculty who are international experts and leading educators in their fields. As a student in this course, you’ll have access to outstanding course directors and faculty.
Course Directors
Lana Tsao
MD | Course Director
Van-Khue Ton
MD, PhD | Course Director
Maxwell Afari, MD
Heart Failure & Transplantation Cardiologist
Julia Allen, NP
Heart Failure & Transplantation Cardiologist
Lori Arrighi, RN
Heart Failure & Transplantation Cardiologist
Christine Albert, MD, MPH
Member of the Faculty of Medicine, Chief of Cardiology
David Berg, MD, MPH
Assistant Professor of Medicine
Brian Bergmark, MD
Assistant Professor of Medicine
Erin Bohula, MD, Dphil
Assistant Professor of Medicine
Samuel Coffin, MD
Heart Failure & Transplantation Cardiologist
Erin Coglianese, MD
Assistant Professor of Medicine
Theresa Comerford, NP
Heart Failure & Transplantation Cardiologist
Jerome Crowley, MD, MPH
Instructor in Anaesthesia
Sarah Cuddy, MD
Assistant Professor of Medicine
Jonathan Cunningham, MD
Assistant Professor of Medicine
David D'Alessandro, MD
Associate Professor of Surgery
Sthuthi David, MD, MSC
Heart Failure & Transplantation Cardiologist
Lisa Defabritiis, BS
Course Administrator
Akshay Desai, MD, MPH
Professor of Medicine
Michael M. Givertz, MD
Professor of Medicine
Ignacio Inglessis-Azuaje, MD
Assistant Professor of Medicine
Ameesh Isath, MBBS
Instructor in Medicine
Karola Jering, MD
Instructor in Medicine
Yuri Kim, MD, PhD
Assistant Professor of Medicine
Ajar Kochar, MD, MHS
Instructor in Medicine
Leah Kosyakovsky, MD
Heart Failure & Transplantation Cardiologist
Raymond Kwong, MD, MPH
Professor of Medicine
Neal K. Lakdawala, MD
Assistant Professor of Medicine
Emily Lau, MD, MPH
Assistant Professor of Medicine
Gregory D. Lewis, MD
Professor of Medicine
Christopher Link, MD
Heart Failure & Transplantation Cardiologist
Jona Ludmir, MD
Assistant Professor of Medicine
Moussa Mansour, MD
Professor of Medicine
Ioannis Mastoris, MD
Instructor in Medicine
Christine McCarthy, MSN, NP
Advanced Nurse Practitioner
Mandeep Mehra, MBBS, MS
Professor of Medicine
Tapan Mehta, MD
Heart Failure & Transplantation Cardiologist
Theofanie Mela, MD
Associate Professor of Medicine
Serguei Melnitchouk, MD
Associate Professor of Surgery
David Miranda, MD
Clinical Fellow in Surgery
Robert Morlend, MD
Heart Failure & Transplantation Cardiologist
David Morrow, MD, MPH
Professor of Medicine
Guilherme Marmontel Nasi, MD
Heart Failure & Transplantation Cardiologist
Christopher Newton Cheh, MD
Heart Failure & Transplantation Cardiologist
Lauren O'Shea, CNP
Advanced Nurse Practitioner in Palliative Care
John Ostrominski, MD, MPH
Cardiovascular Medicine and Obesity Medicine Specialist
Robert Padera, MD, PhD
Associate Professor of Pathology
Nilay Patel, MD
Instructor in Medicine
Jacqueline Ruckel, CNP
Sr. Clinical Nurse Practitioner specializing in Heart Failure & Transplantation
Andrew Schwartzman, MD
Heart Failure & Transplantation Cardiologist
Raghu Seethala, MD, MSC
Assistant Professor of Emergency Medicine
Pinak Shah, MD
Associate Professor of Medicine
Scott Solomon, MD
Professor of Medicine
Garrick Stewart, MD
Assistant Professor of Medicine
Gina Sun, MD
Instructor in Anesthesia
Usha Tedrow, MD, MS
Associate Professor of Medicine
Muthiah Vaduganathan, MD, MPH
Assistant Professor of Medicine
Milica Vukicevic, MD
Heart Failure & Transplantation Cardiologist
Bin Quan Yang, MD
Instructor in Medicine
Evin Yucel, MD
Assistant Professor of Medicine
Daniel Zlotoff, MD, PhD
Assistant Professor of Medicine
Request Information
Interested in learning more about this program? Sign up for details.
Course Fees
Registration Details
You may register through our secure online environment and will receive an email confirmation upon receipt of your payment. Prices include CME credit, electronic syllabus and access to some recordings for 60 days after the course.
At the end of the registration process, a $10 non-refundable processing fee will be added to your registration.
| Role | Course Fee |
|---|---|
| Physician (MD/DO) | $499 |
| Nurse (RN/APRN) | $399 |
| PA | $399 |
| Psychologist | $399 |
| Resident/Fellow | $100 |
| Social Worker | $399 |
| Allied Health Professional / Other | $399 |
Accreditation
The Harvard Medical School designates this Hybrid for a maximum of 20.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For the purpose of recertification, the American Academy of Nurse Practitioners Certification Board and American Nurses Credentialing Center accept AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education). We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.
The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 20.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialists (UEMS). Additional information regarding this agreement may be found on the Union of European Medical Specialists website.
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.